MedImmune Ventures, Inc. 4
4 · G1 Therapeutics, Inc. · Filed Dec 5, 2017
Insider Transaction Report
Form 4
MedImmune Ventures, Inc.
10% Owner
Transactions
- Sale
Common Stock, $0.0001 par value per share
2017-12-01$19.75/sh−133,906$2,644,644→ 3,150,630 total